Who are Lever Bio's investors?

Lever Bio's investors include Claris Ventures, Exor Ventures, Italian Angels for Growth, Club degli Investitori, Ora Global.

Lever Bio

5 known investors

Find your way into Lever Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Lever Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies. The company is focused on in-licensing and advancing promising programs from discovery through preclinical and clinical development stages.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Pietro Puglisi Chief Executive OfficerHe previously worked as an early-stage investor in biotech at Claris Ventures and holds an MSc in Biomedical Engineering from Politecnico di Torino and an MBA from Collège des Ingénieurs.

Investors · 5

Claris Ventures✓ confirmed by Lever BioTorino

How we know: the company's own site · Claris Ventures's portfolio page · funding news · startupbusiness.it · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Exor Ventures✓ confirmed by Lever Bio

How we know: the company's own site · Not right? Tell us

Italian Angels for Growthlisted by Italian Angels for GrowthMilan

How we know: funding news · startupbusiness.it · Not right? Tell us

Club degli InvestitorireportedTurin

How we know: funding news · startupbusiness.it · Not right? Tell us

Ora GlobalreportedNew York

How we know: funding news · startupbusiness.it · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountseed roundDec 2025
Claris Ventures, Club degli Investitori, Italian Angels for Growth, Ora Global
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Lever Bio Raises €4M in Fundingfinsmes.com · May 2025

Frequently asked questions

What does Lever Bio do?: Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies. The company is focused on in-licensing and advancing promising programs from discovery through preclinical and clinical development stages.
Who are Lever Bio's investors?: Lever Bio's investors include Claris Ventures, Exor Ventures, Italian Angels for Growth, Club degli Investitori, Ora Global.